UNSPSC 85512925: Occlusion of left common iliac artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left common iliac artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04LD3ZZ

UNSPSC 85512925, Occlusion of left common iliac artery, percutaneous approach, is a Commodity code whose nominal scope—a specific vascular interventional procedure—does not align with recent state and local procurement activity. The code shows little relevant recent activity; the opportunities posted under this code are solicitations for occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluation services, surgical procedure carve-outs, and emergency medical services for detained youth. None of these services represent the percutaneous occlusion of a specific artery, and the mismatch suggests either miscoding by the issuing bodies or use of this code as a placeholder in procurement databases not designed to capture medical procedure specificity at the level UNSPSC intends.

The six recent opportunities span state departments (Washington State Department of Transportation, on behalf of Washington State Ferries), county governments (Harris County, Collier County, Santa Clara County), municipalities (City of Phoenix, City of Long Beach), and county health systems, with activity posted between July and September 2026 and response dates concentrated in October 2026. None of the work is actually procedural in nature; instead, issuing bodies are buying occupational health administration, benefits administration, staffing placement, and medical evaluation logistics. A firm evaluating pursuit under this code should treat it as misclassified and redirect business development effort toward the actual services sought—health benefits consulting (Pharmacy Benefit Management), occupational health program administration, medical staffing placement, or benefits adjudication—rather than attempt to position interventional vascular capabilities.